EUVIMEDEUVIMED entdecken
Crossref

New research on cannabis and ketamine‐buprenorphine released at APA annual meeting

Alison Knopf

Alcoholism & Drug Abuse Weekly · 25.05.2026 · 38 (21) · 4-5

DOI: 10.1002/adaw.34924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alcoholism & Drug Abuse Weekly, online erschienen am 21.05.2026. Verfasst von Alison Knopf.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New research on the relationship between cannabis and psychosis was released, and a presentation on how low‐dose buprenorphine combined with ketamine reduced suicidality in adults with major depressive disorder was published and presented at the annual meeting of the American Psychiatric Association (APA).

Zitieren

APA

Knopf, A. (2026). New research on cannabis and ketamine‐buprenorphine released at APA annual meeting. Alcoholism & Drug Abuse Weekly, 38(21), 4-5. https://doi.org/10.1002/adaw.34924

Vancouver

Knopf A. New research on cannabis and ketamine‐buprenorphine released at APA annual meeting. Alcoholism & Drug Abuse Weekly. 2026;38(21):4-5. doi:10.1002/adaw.34924

BibTeX
@article{Knopf2026,
  author = {Knopf, Alison},
  title = {New research on cannabis and ketamine‐buprenorphine released at APA annual meeting},
  journal = {Alcoholism & Drug Abuse Weekly},
  year = {2026},
  volume = {38},
  number = {21},
  pages = {4--5},
  doi = {10.1002/adaw.34924}
}
Kostenlos starten →